nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.486	1	CrCtD
Flurandrenolide—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.119	0.601	CbGbCtD
Flurandrenolide—NR3C1—Progesterone—uterine cancer	0.079	0.398	CbGbCtD
Flurandrenolide—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.0362	0.12	CrCrCtD
Flurandrenolide—Drospirenone—Progesterone—uterine cancer	0.0315	0.105	CrCrCtD
Flurandrenolide—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.0291	0.0968	CrCrCtD
Flurandrenolide—Medrysone—Progesterone—uterine cancer	0.0254	0.0844	CrCrCtD
Flurandrenolide—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0253	0.0842	CrCrCtD
Flurandrenolide—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.0244	0.0813	CrCrCtD
Flurandrenolide—Hydrocortamate—Progesterone—uterine cancer	0.0221	0.0734	CrCrCtD
Flurandrenolide—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0213	0.0709	CrCrCtD
Flurandrenolide—Fludrocortisone—Progesterone—uterine cancer	0.0186	0.0618	CrCrCtD
Flurandrenolide—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0185	0.0615	CrCrCtD
Flurandrenolide—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0174	0.0578	CrCrCtD
Flurandrenolide—Prednisolone—Progesterone—uterine cancer	0.0158	0.0525	CrCrCtD
Flurandrenolide—Hydrocortisone—Progesterone—uterine cancer	0.0151	0.0504	CrCrCtD
Flurandrenolide—SERPINA6—oviduct—uterine cancer	0.00302	0.377	CbGeAlD
Flurandrenolide—SERPINA6—renal system—uterine cancer	0.000704	0.0878	CbGeAlD
Flurandrenolide—SERPINA6—female reproductive system—uterine cancer	0.000564	0.0703	CbGeAlD
Flurandrenolide—NR3C1—myometrium—uterine cancer	0.000424	0.0528	CbGeAlD
Flurandrenolide—Eruption—Dactinomycin—uterine cancer	0.0004	0.0754	CcSEcCtD
Flurandrenolide—Folliculitis—Dactinomycin—uterine cancer	0.000391	0.0738	CcSEcCtD
Flurandrenolide—Skin discolouration—Progesterone—uterine cancer	0.000385	0.0726	CcSEcCtD
Flurandrenolide—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000343	0.223	CrCbGaD
Flurandrenolide—Secondary infection—Epirubicin—uterine cancer	0.00034	0.064	CcSEcCtD
Flurandrenolide—NR3C1—epithelium—uterine cancer	0.000333	0.0415	CbGeAlD
Flurandrenolide—NR3C1—uterine cervix—uterine cancer	0.00033	0.0411	CbGeAlD
Flurandrenolide—NR3C1—smooth muscle tissue—uterine cancer	0.00032	0.0399	CbGeAlD
Flurandrenolide—NR3C1—decidua—uterine cancer	0.000314	0.0392	CbGeAlD
Flurandrenolide—Secondary infection—Doxorubicin—uterine cancer	0.000314	0.0592	CcSEcCtD
Flurandrenolide—NR3C1—renal system—uterine cancer	0.000308	0.0384	CbGeAlD
Flurandrenolide—NR3C1—endometrium—uterine cancer	0.000298	0.0372	CbGeAlD
Flurandrenolide—NR3C1—mammalian vulva—uterine cancer	0.000288	0.036	CbGeAlD
Flurandrenolide—Drospirenone—PGR—uterine cancer	0.000286	0.186	CrCbGaD
Flurandrenolide—NR3C1—uterus—uterine cancer	0.000275	0.0343	CbGeAlD
Flurandrenolide—NR3C1—female reproductive system—uterine cancer	0.000247	0.0308	CbGeAlD
Flurandrenolide—Infection—Carboplatin—uterine cancer	0.000235	0.0443	CcSEcCtD
Flurandrenolide—Leukoderma—Epirubicin—uterine cancer	0.000235	0.0442	CcSEcCtD
Flurandrenolide—NR3C1—female gonad—uterine cancer	0.000225	0.028	CbGeAlD
Flurandrenolide—NR3C1—vagina—uterine cancer	0.000223	0.0278	CbGeAlD
Flurandrenolide—Leukoderma—Doxorubicin—uterine cancer	0.000217	0.0409	CcSEcCtD
Flurandrenolide—Skin discolouration—Etoposide—uterine cancer	0.000197	0.0372	CcSEcCtD
Flurandrenolide—Medroxyprogesterone Acetate—PGR—uterine cancer	0.000191	0.124	CrCbGaD
Flurandrenolide—Betamethasone—PGR—uterine cancer	0.000173	0.113	CrCbGaD
Flurandrenolide—Eruption—Epirubicin—uterine cancer	0.000162	0.0306	CcSEcCtD
Flurandrenolide—Folliculitis—Epirubicin—uterine cancer	0.000159	0.0299	CcSEcCtD
Flurandrenolide—Eruption—Doxorubicin—uterine cancer	0.00015	0.0283	CcSEcCtD
Flurandrenolide—Folliculitis—Doxorubicin—uterine cancer	0.000147	0.0277	CcSEcCtD
Flurandrenolide—NR3C1—lymph node—uterine cancer	0.000145	0.018	CbGeAlD
Flurandrenolide—Dexamethasone—CYP11A1—uterine cancer	0.000134	0.087	CrCbGaD
Flurandrenolide—Infection—Progesterone—uterine cancer	0.000123	0.0233	CcSEcCtD
Flurandrenolide—Medroxyprogesterone Acetate—ESR1—uterine cancer	0.00012	0.0784	CrCbGaD
Flurandrenolide—Betamethasone—CYP19A1—uterine cancer	0.000119	0.0774	CrCbGaD
Flurandrenolide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000112	0.0211	CcSEcCtD
Flurandrenolide—Skin discolouration—Epirubicin—uterine cancer	0.00011	0.0208	CcSEcCtD
Flurandrenolide—Skin discolouration—Doxorubicin—uterine cancer	0.000102	0.0193	CcSEcCtD
Flurandrenolide—Dexamethasone—PGR—uterine cancer	0.000101	0.0656	CrCbGaD
Flurandrenolide—Dermatitis contact—Epirubicin—uterine cancer	9.86e-05	0.0186	CcSEcCtD
Flurandrenolide—Hypersensitivity—Progesterone—uterine cancer	9.15e-05	0.0172	CcSEcCtD
Flurandrenolide—Dermatitis contact—Doxorubicin—uterine cancer	9.13e-05	0.0172	CcSEcCtD
Flurandrenolide—Pruritus—Progesterone—uterine cancer	8.78e-05	0.0166	CcSEcCtD
Flurandrenolide—Infection—Dactinomycin—uterine cancer	8.72e-05	0.0164	CcSEcCtD
Flurandrenolide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	8.29e-05	0.0156	CcSEcCtD
Flurandrenolide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	7.96e-05	0.015	CcSEcCtD
Flurandrenolide—Rash—Progesterone—uterine cancer	7.83e-05	0.0148	CcSEcCtD
Flurandrenolide—Dermatitis—Progesterone—uterine cancer	7.82e-05	0.0147	CcSEcCtD
Flurandrenolide—Rash—Medroxyprogesterone Acetate—uterine cancer	7.09e-05	0.0134	CcSEcCtD
Flurandrenolide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	7.09e-05	0.0134	CcSEcCtD
Flurandrenolide—Dexamethasone—CYP19A1—uterine cancer	6.91e-05	0.045	CrCbGaD
Flurandrenolide—Hypersensitivity—Dactinomycin—uterine cancer	6.47e-05	0.0122	CcSEcCtD
Flurandrenolide—Infection—Etoposide—uterine cancer	6.31e-05	0.0119	CcSEcCtD
Flurandrenolide—Rash—Dactinomycin—uterine cancer	5.53e-05	0.0104	CcSEcCtD
Flurandrenolide—Hypersensitivity—Etoposide—uterine cancer	4.68e-05	0.00882	CcSEcCtD
Flurandrenolide—Pruritus—Etoposide—uterine cancer	4.49e-05	0.00847	CcSEcCtD
Flurandrenolide—Rash—Etoposide—uterine cancer	4e-05	0.00755	CcSEcCtD
Flurandrenolide—Dermatitis—Etoposide—uterine cancer	4e-05	0.00754	CcSEcCtD
Flurandrenolide—Infection—Epirubicin—uterine cancer	3.54e-05	0.00667	CcSEcCtD
Flurandrenolide—Infection—Doxorubicin—uterine cancer	3.27e-05	0.00617	CcSEcCtD
Flurandrenolide—Hypersensitivity—Epirubicin—uterine cancer	2.62e-05	0.00494	CcSEcCtD
Flurandrenolide—Pruritus—Epirubicin—uterine cancer	2.52e-05	0.00475	CcSEcCtD
Flurandrenolide—Hypersensitivity—Doxorubicin—uterine cancer	2.43e-05	0.00457	CcSEcCtD
Flurandrenolide—Pruritus—Doxorubicin—uterine cancer	2.33e-05	0.00439	CcSEcCtD
Flurandrenolide—Rash—Epirubicin—uterine cancer	2.24e-05	0.00423	CcSEcCtD
Flurandrenolide—Dermatitis—Epirubicin—uterine cancer	2.24e-05	0.00423	CcSEcCtD
Flurandrenolide—Rash—Doxorubicin—uterine cancer	2.08e-05	0.00392	CcSEcCtD
Flurandrenolide—Dermatitis—Doxorubicin—uterine cancer	2.08e-05	0.00391	CcSEcCtD
